Multispecific drugs: the fourth wave of biopharmaceutical innovation
Open Access
- 4 June 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 5 (1), 1-2
- https://doi.org/10.1038/s41392-020-0201-3
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Multispecific drugs herald a new era of biopharmaceutical innovationNature, 2020
- Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer ImmunityCancer Immunology Research, 2019
- PROteolysis TArgeting Chimeras (PROTACs) — Past, present and futureDrug Discovery Today: Technologies, 2019
- Strategies and challenges for the next generation of antibody–drug conjugatesNature Reviews Drug Discovery, 2017
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros ProteinsScience, 2014